logo
Select company
Select metric
-36.17%EBITDA Margin
VS
Market
17
Sector
48
Industry
36
History
94
$ 6.42Close
$ 4.4 - $ 34 52-Week Range
Ticker Information

Ticker

BDSX

Company Name

BIODESIX INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

BIODESIX INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BDSX - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -27.69M-36.17%$ 76.56M
3/31/2025$ -27.11M-36.41%$ 74.46M
12/31/2024$ -28.9M-40.52%$ 71.32M
9/30/2024$ -29.62M-45.18%$ 65.56M
6/30/2024$ -30.14M-49.5%$ 60.9M
3/31/2024$ -32.1M-58.52%$ 54.85M
12/31/2023$ -37.1M-75.59%$ 49.09M
9/30/2023$ -47.74M-108.44%$ 44.03M
6/30/2023$ -49.41M-118.66%$ 41.64M
3/31/2023$ -53.04M-130.25%$ 40.72M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIODESIX INC's latest trailing twelve months (TTM) EBITDA % stands at -101.52%.
  • Over the past 5 years, BIODESIX INC's average EBITDA % has been -80.36%.
  • The median EBITDA % for BIODESIX INC during this period was -65.08%
  • BIODESIX INC reached its highest EBITDA % over the past 5 years at -31.02%.
  • The lowest EBITDA % recorded by BIODESIX INC in the same timeframe -148.76%

BIODESIX INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
TELA : TELA BIO INC -46.1%LUNG : PULMONX CORP -55.87%FONR : FONAR CORP 15.49%FBIO : FORTRESS BIOTECH INC 10.38%STRR1 : STAR EQUITY HOLDINGS INC 3.56%STRO : SUTRO BIOPHARMA INC -162.52%VNRX : VOLITIONRX LTD -1637.33%MYO : MYOMO INC -18.17%IMDX : INSIGHT MOLECULAR DIAGNOSTICS INC -1441.13%APYX : APYX MEDICAL CORP -22.59%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for BIODESIX INC is calculated as follows: EBITDA [ $ -24.93M ] / Revenues [ $ 24.55M ]
(=) EBITDA % [ -101.52% ]

BDSX - EBITDA Margin, Last 5 years

-148.76%

Minimum

Jun 30, 2022

-31.02%

Maximum

Jun 30, 2021

-80.36%

Average

-65.08%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-75.07%
max97.73%
average16.12%
median14.72%
std26.88%